KARD

Kardigan, Inc.

• NASDAQ·09/03 03:20

  6 Biotech Stocks To Watch Ahead Of Key Catalysts: RenovoRx, Eupraxia, Connect Bio, Kardigan & More

• TipRanks·09/02 16:30

  Kardigan’s Tonlamarsen Trial Targets Severe Hypertension: What Investors Should Watch

• TipRanks·09/02 16:30

  Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ Radar

• Dow Jones·08/25 13:06

  Kardigan Is Maintained at Overweight by JP Morgan

• Dow Jones·08/25 13:06

  Kardigan Price Target Cut to $46.00/Share From $51.00 by JP Morgan

• Benzinga·08/25 12:55

  JP Morgan Maintains Overweight on Kardigan, Lowers Price Target to $46

• TipRanks·08/25 12:00

  Kardigan price target lowered to $46 from $51 at JPMorgan

• Benzinga·08/11 11:55

  Kardigan Q2 EPS $(4.61) Misses $(0.71) Estimate

• TipRanks·07/31 04:35

  2 ‘Strong Buy’ IPO Stocks JPMorgan Thinks Are Worth Watching

• Dow Jones·07/13 18:32

  Kardigan Price Target Announced at $46.00/Share by TD Cowen

• Benzinga·07/13 18:23

  TD Cowen Initiates Coverage On Kardigan with Buy Rating, Announces Price Target of $46

• Dow Jones·07/13 18:07

  Kardigan Price Target Announced at $37.00/Share by Leerink Partners

• Dow Jones·07/13 18:07

  Kardigan Initiated at Outperform by Leerink Partners

• Benzinga·07/13 17:57

  Leerink Partners Initiates Coverage On Kardigan with Outperform Rating, Announces Price Target of $37

• TipRanks·07/13 16:40

  Opening Day: SK Hynix makes loud U.S. arrival in otherwise quiet week for IPOs